Baxter International | BAX - Umsatzerlöse





Der Umsatz Veränderung Datum
Abbott USD 12.59B 1.43B 2026-06
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 153.6M 12.4M 2026-06
Baxter International USD 2.96B 260M 2026-06
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.44B 240M 2026-06
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.31B 120M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Fresenius EUR 5.95B 210M 2026-06
Globus Medical USD 759.85M 66.55M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
ICU Medical USD 525.77M 14.93M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
J&J USD 25.31B 1.21B 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 418.8M 36.9M 2026-06
Quest Diagnostics USD 3.04B 140M 2026-06
Smith & Nephew USD 1.6B 1.58B 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Terumo JPY 300.32B 3.69B 2026-03
Zimmer Biomet Holdings USD 2.18B 90M 2026-06